FDA approves first RSV vaccine

May 22, 2023•1 min read

Drug makers have been racing at a breakneck pace to develop respiratory syncytial virus (RSV) vaccines this year. On May 3, the U.S. Food and Drug Administration (FDA) announced it has approved Arexvy, the first-ever RSV vaccine for individuals 60 and over.

Montana BioScience Alliance

Montana BioScience Alliance is the statewide organization dedicated to advancing and advocating for Montana’s bioscience industry. The Alliance connects researchers, companies, and policymakers to strengthen research, support responsible policy, and drive economic growth across the state.

Back to Blog